List of Tables
Table 1. Global Viral Vector and Plasmid DNA Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of AAV
Table 3. Key Players of Lentiviruses
Table 4. Key Players of Retroviruses
Table 5. Key Players of Adenoviruses
Table 6. Key Players of DNA Plasmids
Table 7. Key Players of Other
Table 8. Global Viral Vector and Plasmid DNA Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Viral Vector and Plasmid DNA Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Viral Vector and Plasmid DNA Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Viral Vector and Plasmid DNA Market Share by Region (2020-2025)
Table 12. Global Viral Vector and Plasmid DNA Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Viral Vector and Plasmid DNA Market Share by Region (2026-2031)
Table 14. Viral Vector and Plasmid DNA Market Trends
Table 15. Viral Vector and Plasmid DNA Market Drivers
Table 16. Viral Vector and Plasmid DNA Market Challenges
Table 17. Viral Vector and Plasmid DNA Market Restraints
Table 18. Global Viral Vector and Plasmid DNA Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Viral Vector and Plasmid DNA Market Share by Players (2020-2025)
Table 20. Global Top Viral Vector and Plasmid DNA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA as of 2024)
Table 21. Ranking of Global Top Viral Vector and Plasmid DNA Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Viral Vector and Plasmid DNA Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Viral Vector and Plasmid DNA, Headquarters and Area Served
Table 24. Global Key Players of Viral Vector and Plasmid DNA, Product and Application
Table 25. Global Key Players of Viral Vector and Plasmid DNA, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral Vector and Plasmid DNA Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2020-2025)
Table 29. Global Viral Vector and Plasmid DNA Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2026-2031)
Table 31. Global Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Viral Vector and Plasmid DNA Revenue Market Share by Application (2020-2025)
Table 33. Global Viral Vector and Plasmid DNA Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Viral Vector and Plasmid DNA Revenue Market Share by Application (2026-2031)
Table 35. North America Viral Vector and Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Viral Vector and Plasmid DNA Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Viral Vector and Plasmid DNA Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Viral Vector and Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Viral Vector and Plasmid DNA Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Viral Vector and Plasmid DNA Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Viral Vector and Plasmid DNA Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Viral Vector and Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Viral Vector and Plasmid DNA Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Viral Vector and Plasmid DNA Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Viral Vector and Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2026-2031) & (US$ Million)
Table 50. Thermo Fisher Scientific Company Details
Table 51. Thermo Fisher Scientific Business Overview
Table 52. Thermo Fisher Scientific Viral Vector and Plasmid DNA Product
Table 53. Thermo Fisher Scientific Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 54. Thermo Fisher Scientific Recent Development
Table 55. Lonza Company Details
Table 56. Lonza Business Overview
Table 57. Lonza Viral Vector and Plasmid DNA Product
Table 58. Lonza Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 59. Lonza Recent Development
Table 60. Azenta Life Sciences Company Details
Table 61. Azenta Life Sciences Business Overview
Table 62. Azenta Life Sciences Viral Vector and Plasmid DNA Product
Table 63. Azenta Life Sciences Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 64. Azenta Life Sciences Recent Development
Table 65. Revvity Company Details
Table 66. Revvity Business Overview
Table 67. Revvity Viral Vector and Plasmid DNA Product
Table 68. Revvity Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 69. Revvity Recent Development
Table 70. VectorBuilder Company Details
Table 71. VectorBuilder Business Overview
Table 72. VectorBuilder Viral Vector and Plasmid DNA Product
Table 73. VectorBuilder Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 74. VectorBuilder Recent Development
Table 75. Takara Bio Company Details
Table 76. Takara Bio Business Overview
Table 77. Takara Bio Viral Vector and Plasmid DNA Product
Table 78. Takara Bio Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 79. Takara Bio Recent Development
Table 80. GenScript Biotech Company Details
Table 81. GenScript Biotech Business Overview
Table 82. GenScript Biotech Viral Vector and Plasmid DNA Product
Table 83. GenScript Biotech Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 84. GenScript Biotech Recent Development
Table 85. Gene Chem Company Details
Table 86. Gene Chem Business Overview
Table 87. Gene Chem Viral Vector and Plasmid DNA Product
Table 88. Gene Chem Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 89. Gene Chem Recent Development
Table 90. Geno Meditech Company Details
Table 91. Geno Meditech Business Overview
Table 92. Geno Meditech Viral Vector and Plasmid DNA Product
Table 93. Geno Meditech Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 94. Geno Meditech Recent Development
Table 95. PackGene Biotech Company Details
Table 96. PackGene Biotech Business Overview
Table 97. PackGene Biotech Viral Vector and Plasmid DNA Product
Table 98. PackGene Biotech Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 99. PackGene Biotech Recent Development
Table 100. VIROVEK Company Details
Table 101. VIROVEK Business Overview
Table 102. VIROVEK Viral Vector and Plasmid DNA Product
Table 103. VIROVEK Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 104. VIROVEK Recent Development
Table 105. OriGen Company Details
Table 106. OriGen Business Overview
Table 107. OriGen Viral Vector and Plasmid DNA Product
Table 108. OriGen Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 109. OriGen Recent Development
Table 110. Vector BioLabs Company Details
Table 111. Vector BioLabs Business Overview
Table 112. Vector BioLabs Viral Vector and Plasmid DNA Product
Table 113. Vector BioLabs Revenue in Viral Vector and Plasmid DNA Business (2020-2025) & (US$ Million)
Table 114. Vector BioLabs Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Authors List of This Report
List of Figures
Figure 1. Viral Vector and Plasmid DNA Picture
Figure 2. Global Viral Vector and Plasmid DNA Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viral Vector and Plasmid DNA Market Share by Type: 2024 VS 2031
Figure 4. AAV Features
Figure 5. Lentiviruses Features
Figure 6. Retroviruses Features
Figure 7. Adenoviruses Features
Figure 8. DNA Plasmids Features
Figure 9. Other Features
Figure 10. Global Viral Vector and Plasmid DNA Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Viral Vector and Plasmid DNA Market Share by Application: 2024 VS 2031
Figure 12. Pharmaceutical and Biopharmaceutical Companies Case Studies
Figure 13. Academics and Research Institutes Case Studies
Figure 14. Viral Vector and Plasmid DNA Report Years Considered
Figure 15. Global Viral Vector and Plasmid DNA Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Viral Vector and Plasmid DNA Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Viral Vector and Plasmid DNA Market Share by Region: 2024 VS 2031
Figure 18. Global Viral Vector and Plasmid DNA Market Share by Players in 2024
Figure 19. Global Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Viral Vector and Plasmid DNA Revenue in 2024
Figure 21. North America Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Viral Vector and Plasmid DNA Market Share by Country (2020-2031)
Figure 23. United States Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Viral Vector and Plasmid DNA Market Share by Country (2020-2031)
Figure 27. Germany Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Viral Vector and Plasmid DNA Market Share by Region (2020-2031)
Figure 35. China Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Viral Vector and Plasmid DNA Market Share by Country (2020-2031)
Figure 43. Mexico Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Viral Vector and Plasmid DNA Market Share by Country (2020-2031)
Figure 47. Israel Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Viral Vector and Plasmid DNA Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 51. Lonza Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 52. Azenta Life Sciences Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 53. Revvity Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 54. VectorBuilder Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 55. Takara Bio Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 56. GenScript Biotech Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 57. Gene Chem Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 58. Geno Meditech Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 59. PackGene Biotech Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 60. VIROVEK Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 61. OriGen Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 62. Vector BioLabs Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
